BackApexigen Overview

Apexigen Current Cash

Track Apexigen's current cash ($9.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$9.37M
↓ 87.83% YoYΔ $-67.60M vs prior year quarter

Peer trimmed avg / median

Loading

Apexigen Current Cash History

Loading

Apexigen vs. peers: Current Cash Comparison

Loading

Apexigen Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Apexigen (APGN) FAQ

The latest current cash for APGN is $9.4M as of June 2023. That compares with $77M in the prior-year period — down 87.8% year over year. Investors often review this figure alongside Apexigen's historical trend and sector peers before judging valuation or financial health.

Over the past year, APGN's current cash moved from $77M to $9.4M — a 87.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Apexigen's operating scale or balance-sheet position.

A current cash figure of $9.4M for APGN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting APGN's current cash ($9.4M), review year-over-year change from $77M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.